Hygieia Labs Incorporated (Hygieia Labs), a Nevada Corporation, is an ambitious innovative new company that is attempting to turn the medical marijuana industry on its head.



With an experienced executive at the helm as CEO and Chairman, Hygieia Labs intends to grow at more than 50% per year through acquisition, solid customer service, a great sales plan, proven competitive strategies, and a group of people that bring dynamic energy to the company.


The goal for this plan is financial: Hygieia Labs is seeking investment capital to fund its multiple ventures in the medical marijuana industry; this document is one step in the process. It is also a road map for the company. The document gives all present and future employees, as well as the owner a sense of purpose that may not exist without the business plan but becomes more relevant after the business plan is written, reviewed, shared, and edited by all. It is a living document that will last far beyond the capital acquiring purpose, or if that doesn't occur, to bring an investor on board.


Hygieia Labs is a Nevada Corporation, and has been lobbying hard for the Decriminalization of Cannabis Research, which makes us a player that is serious about Medical Marijuana Issues.


"Hygieia Labs is a tenured group of cannabis professionals dedicated to providing the highest quality medicine, service, and experience to registered medical marijuana patients. We are passionate citizens that strive to enhance the lives of our patients while changing the perception of marijuana as a viable and safe medicine for an array of conditions.”

Hygieia Labs is an active member of the community through social action and philanthropy because we understand that we cannot succeed unless our neighbors do too.


Our main market is the ever-growing medical marijuana patient community. Our base market is within the State of California with ancillary markets in Colorado, Washington and Massachusetts. With the number of states passing legalization laws, we expect that within 5 years, cannabis will be legal in all 50 states and the Federal Government will reclassify and remove the federal restrictions currently in place.

Twenty-three states and the District of Columbia have enacted effective medical marijuana laws thus far. These laws are working well and protecting patients.

A clear majority of the public and many prominent religious and medical organizations support seriously ill patients' right to use medical marijuana without risking arrest and imprisonment.


Studies show that many patients suffering with HIV/AIDS, glaucoma, cancer and chemotherapy, multiple sclerosis, epilepsy, and other debilitating illnesses find that marijuana provides relief from their symptoms.

"Nausea, appetite loss, pain and anxiety are all afflictions of wasting and can be mitigated by marijuana."

— Institute of Medicine, Marijuana and Medicine: Assessing the Science Base, 1999

"ACP urges an evidence-based review of marijuana's status as a Schedule I controlled substance to determine whether it should be reclassified to a different schedule. ... ACP strongly supports exemption from federal criminal prosecution; civil liability; or professional sanctioning, such as loss of licensure or credentialing, for physicians who prescribe or dispense medical marijuana in accordance with state law. Similarly, ACP strongly urges protection from criminal or civil penalties for patients who use medical marijuana as permitted under state laws. ... Evidence not only supports the use of medical marijuana in certain conditions but also suggests numerous indications for cannabinoids."

— American College of Physicians, Supporting Research into the Therapeutic Role of Marijuana, 2008

Available prescription drugs often come with far more serious side effects than marijuana, and many patients who find relief from marijuana simply do not respond to prescription medications. Smoking or vaporizing marijuana are much more effective delivery methods than pills for many patients; the drug works instantly, the dosage may be controlled by the patient, and there is no problem "keeping it down" since it cannot be vomited back up.

Cocaine, morphine, and methamphetamine may all be legally administered to patients — so why not marijuana, which has a far lower rate of dependency and on which no one has ever overdosed?


Under state law, 23 states and Washington, D.C. currently provide legal protection for seriously ill patients whose doctors recommend the medical use of marijuana: Alaska, Arizona, California, Connecticut, Colorado, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, Oregon, Rhode Island, Washington, and Vermont. Twenty-two of those states issue ID cards to patients who provide their doctors' recommendations to a state or county agency.

Generally, these laws are working well and providing patients with relief and protection from arrest. Since 1996, when the first effective medical marijuana law passed, data have shown that concerns about these laws increasing youth marijuana use are unfounded. None of the 15 states with available data have experienced a statistically significant overall increase in youth marijuana use since the laws' enactment. Instead, several of the states have reported overall decreases.


Because about 99% of all marijuana arrests occur at the state and local levels, state medical marijuana laws provide nearly complete protection to patients. President Barack Obama has said that the federal government will not prosecute patients in compliance with state medical marijuana laws.

Federal law does not prevent states from removing state criminal penalties for the medical use of marijuana. Nothing in the U.S. Constitution or federal law prohibits states from enacting penalties that differ from federal law.

The U.S. Supreme Court's 2005 ruling in Gonzales vs. Raich did not change states' ability to enact medical marijuana laws. The ruling simply maintained the status quo by affirming that the federal government may prosecute medical marijuana patients.

A federal appellate court has ruled that the federal government cannot punish — or even investigate — physicians for discussing or recommending the medical use of marijuana with patients.


A May 2018 Fox News poll found that 85% of Americans think "adults should be allowed to use marijuana for medical purposes if a physician prescribes it.”

Voters in 11 states have enacted medical marijuana laws by statewide ballot initiatives. In Michigan in 2008, the medical marijuana initiative received 63% of the vote, more than the 57% Pres. Obama received in the state. In November 2010, Arizonans passed a medical marijuana law in an election that saw overwhelming Republican victories on every level of that state. Most recently, in November 2012, 63% of Massachusetts voters supported a ballot initiative to enact a compassionate medical marijuana program in their state. There, too, medical marijuana received a larger percent of the votes than Pres. Obama, who got 60% of the vote in Massachusetts.


  • American College of Physicians
  • Institute of Medicine
  • American Public Health Association
  • American Nurses Association
  • American Academy of HIV Medicine
  • Leukemia and Lymphoma Society
  • Lymphoma Foundation of America
  • American Medical Student Association
  • Epilepsy Foundation
  • The State Medical Societies of New York, Rhode Island, and California

The American Medical Association "calls for further adequate and well-controlled studies of marijuana" and believes that "effective patient care requires the free and unfettered exchange of information on treatment alternatives and that discussion of these alternatives between physicians and patients should not subject either party to criminal sanctions." In 2009, the AMA recommended the federal government consider reclassifying marijuana to facilitate research. That same year, delegates voted down a resolution saying that “smoked marijuana should not be recommended for medical use." — These views stand in sharp contrast to the actions of the federal government, which has systematically hampered research and attempted (unsuccessfully) to bar doctors from recommending marijuana to their patients.


The purpose of the Company is to engage in all lawful activities, including, but not limited to the following activities:

  • Sales and support of medical cannabis / marijuana products and services through our website https://www.rxgreenthumb.com and affiliate dealers, dispensaries and delivery service agents.
  • Produce and market Hygieia Labs oils and infused products. A variety of cannabis oil extracts, developed specifically for the treatment of neurological disorders including Epilepsy, Parkinson's, MS and Dementia.
  • Infused medicinal and recreational products infused with cannabis oils such as beverages, oils (olive, coconut etc.), edibles and topical.
  • Brand and market Hygieia-Labs ‘Purple Knight’, a cannabis extract that is used to treat spasms caused by Multiple Sclerosis, Epilepsy, and Parkinson’s disease.
  • Establish branded strains and make cannabis-infused edibles, hash oils and cannabis-based topical body lotions.
  • Market cannabis and hemp-based edibles that would be qualified for sale in all 50 states.
  • Support research and development of pancreatic and breast cancer treatments based on medicinal marijuana.
  • Research and development of medical cures centered on cannabis and hemp products.
  • To develop the company’s role in medicinal uses for cannabis medical marijuana, which is often prescribed as a treatment for chemotherapy-induced nausea.
  • Pursue licensing for the cultivation and sale of marijuana for recreational and medicinal uses with the intention of developing, operating and maintaining our own greenhouses and retail outlets.
  • Develop and operate cannabis grow rooms to produce and control the necessary raw materials needed in our final products


The company is very knowledgeable in all aspects of the Medical Marijuana Marketplace, and considers itself a leader in the safe and professional refinement of cannabis to ensure the highest quality products for the consumer.


Hygieia Labs Cannabis Oil Extracts

Hygieia Labs - Purple Knight THC Oils

Hygieia Labs product lines include cannabis oil extracts produced by a proprietary and patent pending process that extracts a pure oil without use of harmful butane and other dangerous gases. Hygieia Labs uses a proprietary extraction process coupled with a patent pending pesticide removal process to produce the purest form of cannabis extracts without pesticides.

Hygieia Labs Cannabis Oil Product Line Expansion

We are also expanding into the Medibles field with future products being developed in the Edibles, High End Chocolate and Confections Market Place.

The Chocolates are custom manufactured under the close personal attention of a professional chocolatier.

The latest extraction equipment and technology is seamlessly combined with scientific cannabis refinement techniques and traditional chocolate production methods to ensure consistently excellent flavor and reliable dosage.

Hygieia Labs Cannabis Oil Extracts ROI Estimates

Example 6 - 15 Lbs Capacity Incredible Profit Potentials:

  • Yields Cannabis Oil Extracts that currently sell for $35.00 per gram wholesale and $65.00 per gram retail.
  • Example: 15 Pounds of marijuana flowers yields an average of 1,494.90 grams of pure Cannabis Oil by using our proprietary extraction methods.
  • 15 Pounds cost: $2,000.00 / pound x 15 = $30,000.00 Botanical Cost
  • 15 Pounds Yield: 22% Oil
  • 15 Pounds x 453 grams per pound x 22% = 1,494.90 grams oil
  • 1,494.90 grams x $35.0 per gram = $52,321.50 (Wholesale)
  • 1,494.90 grams x $65.0 per gram = $97,110.50 (Retail)
  • Revenues: Yield: $52,321.50 - $30,000.00 - $2,197.60 Processing Fees = $20,123.90 Profit on 15 Pounds!

 Yearly Production Estimates Tier 11 Massachusetts

  • 14,256 lbs Annually
  • 1 pound production cost $325.00 / lb
  • 14,256 lbs x $325.00 /lb = $4,633,200.00 Botanical Cost
  • 14,256 lbs x 453 grams per pound x 22% = 1,420,752.90 grams
  • 1,420,752.90 grams x $35.00 per gram = $49,726,351.00 (Wholesale)
  • 1,420,752.90 grams x $65.00 per gram = $92,348,938.00 (Retail)
  • Revenues: Yield: $49,726,351.00 - $4,633,200.00 - $468,243.00 Processing Fees = $44,624,908.00 Annually 

*Payback and Return on Investment ROI: The Revenue Estimates are only provided for illustration purposes, since your operator, type botanical, and costs/profits will vary.

Grow Rooms

Growing and producing our own lines of cannabis strains. We estimate a grow room total size of 100,000 sq ft based on Massachusetts Cannabis Control Commission license availability. These strains will be processed, and the extracted components will be used in our products. This gives us complete quality control from seed to shelf.

The company will be introducing innovative new products through applied state-of-the-art cannabis science.  


Hygieia Labs continues to expand its distribution within the State of California and plans expansion to other legal cannabis states across the country.

Over the last year, Owner funding and cash flow has fueled the company’s initial growth. In order to maintain leadership of this emerging economic opportunity, Hygieia Labs, is seeking funding to fuel growth in California and implement its Massachusetts expansion plan.  


Hygieia Labs is conducting a private offering of:

  • 10,000,000 shares of common stock
  • At $1.00 per Share
  • For an aggregate offering price of $10,000,000
  • Minimum purchase 100,000 Shares for $100,000*

*See Offering Memorandum for details.


No money or other consideration is being solicited by means of this announcement or will be accepted. An indication of interest made by a prospective purchaser shall involve no obligation or commitment of any kind. No sales will be made, or commitment to purchase accepted until 5 business days of delivery of a written offering disclosure statement and subscription information to the prospective purchaser in accordance with the requirements of the Nevada Corporations Code.

For more complete information about Hygieia Labs Incorporated, please contact:  

* We may wave such minimum at our sole discretion.



In the area of graphical user interfaces (GUI), a tabbed document interface (TDI) or a Tab is one that allows multiple documents to be contained within a single window, using tabs as a navigational widget for switching between sets of documents. It is an interface style most commonly associated with web browsers, web applications, text editors, and preference panes.

GUI tabs are modeled after traditional card tabs inserted in paper files or card indexes (in keeping with the desktop metaphor).

In the area of graphical user interfaces (GUI), a tabbed document interface (TDI) or a Tab is one that allows multiple documents to be contained within a single window, using tabs as a navigational widget for switching between sets of documents. It is an interface style most commonly associated with web browsers, web applications, text editors, and preference panes.

GUI tabs are modeled after traditional card tabs inserted in paper files or card indexes (in keeping with the desktop metaphor).